June S&P 500 E-Mini futures (ESM24) are down -0.52%, and June Nasdaq 100 E-Mini futures (NQM24) are down -0.29% this morning after both the benchmark S&P 500 and tech-heavy Nasdaq 100 posted their fourth...
June S&P 500 futures (ESM23) are up +0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.09% this morning as weak trade data from China stoked investor concerns over the strength of global demand....
Novavax and Vaxart have each dropped more than 80% over the past year.
Select analysts believe these industry game changers can skyrocket over the next year.
Investors looking for bargains should look elsewhere.
Top-line data from COVID-19 Phase II study expected in the third quarter of 2022 Vaxart initiates work on vaccine candidates that directly target new...
Non-executive director to bring extensive life science industry and finance experience SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) --...
All six proposals approved in the 2022 Proxy Statement Vote strengthens the Company as it progresses its oral vaccine programs SOUTH SAN FRANCISCO,...
Vaxart is still in the coronavirus vaccine race, even though its competitors remain very far ahead.
Conference call to begin at 4:30 p.m. ET...